You are here: Industry Insights > Inflammation

News List

Research Progress on the Application of Biologics in Childhood Asthma. Xiaomichong
October 30, 2023
Asthma is a heterogeneous, complex chronic disease. Children with severe asthma often experience acute exacerbations, leading to impaired lung function and poor quality of life.
Novel Autoantibody Adds Fuel to COVID-19 “Firestorm” of Inflammation, Blood Clots firstwordpharma
July 20, 2021
Researchers at Michigan Medicine have discovered yet another functional autoantibody in COVID-19 patients that contributes to the disease's development and the "firestorm" of blood clots and inflammation it induces.
Gossamer Bio Appoints Sandra Milligan to its Board of Directors firstwordpharma
June 15, 2021
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics today announced the appointment of Sandra Milligan, M.D., J.D., to its Board of Directors.
CytoSorbents Announces Approval of CytoSorb® in Korea in Collaboration with Partner Fresenius Medical Care prnasia
January 21, 2021
CytoSorbents Corporation, a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients around the world, announces that the Korean Ministry ...
Study recommends steroid treatment should be given only to sickest COVID-19 patients expresspharma
November 16, 2020
While dexamethasone and other steroids are prescribed to treat cytokine storms, these drugs can backfire in patients whose immune response is already suppressed.
SPARC announces Phase 3 trial results of SDN-037 to treat inflammation and pain of ocular surgery expresspharma
October 16, 2020
The primary efficacy measure was the proportion of subjects with an anterior chamber cell (ACC) grade of zero (0) on Day 15 (zero inflammation) which was met by a statistically significant number, reveal the positive top-line results.
Inflammation key to severe COVID-19 in high-risk groups: Study expresspharma
July 08, 2020
A small study of high-risk COVID-19 patients may help explain why their health issues contribute to more severe cases of the illness. Chronic conditions like obesity, diabetes, liver disease, hypertension, and heart disease also cause inflammation.
Inflammation Linked to Thyroid Dysfunction in Psoriasis Patients drugs
December 31, 2019
While the rate of thyroid dysfunction among patients with psoriasis generally is not higher than expected, psoriasis in patients with thyroid dysfunction is more clinically severe and ...
Health Threats Don't End for Some Sepsis Survivors drugs
August 12, 2019
Sepsis is a life-threatening infection that lands its victims in the hospital, but the dangers don't end for survivors who have high levels of inflammation long after being discharged, a new study finds.
Biologic Tx for Psoriasis May Reduce Coronary Inflammation drugs
August 01, 2019
For patients with moderate-to-severe psoriasis, the perivascular fat attenuation index (FAI)...

Previous page 1 2 3 Next page